S. James Matthews

972 total citations
24 papers, 674 citations indexed

About

S. James Matthews is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, S. James Matthews has authored 24 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Pharmacology and 3 papers in Infectious Diseases. Recurrent topics in S. James Matthews's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Urinary Tract Infections Management (3 papers) and Hepatitis C virus research (3 papers). S. James Matthews is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Urinary Tract Infections Management (3 papers) and Hepatitis C virus research (3 papers). S. James Matthews collaborates with scholars based in United States, United Kingdom and New Zealand. S. James Matthews's co-authors include Jason W. Lancaster, Christopher McCoy, Richard A. Gleckman, Salvador Álvarez, Margarita V. DiVall, Michael J. Gonyeau, Donna M. Qualters, Jennifer Trujillo, Judith T. Barr and Robert J. Cersosimo and has published in prestigious journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and Clinical Therapeutics.

In The Last Decade

S. James Matthews

23 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. James Matthews United States 14 230 127 85 85 84 24 674
Christopher McCoy United States 19 199 0.9× 187 1.5× 101 1.2× 37 0.4× 137 1.6× 43 965
LeAnn B. Norris United States 15 122 0.5× 49 0.4× 67 0.8× 48 0.6× 36 0.4× 38 790
Siméon Pierre Choukem Cameroon 14 144 0.6× 88 0.7× 34 0.4× 42 0.5× 74 0.9× 70 652
Ignacio Segarra Spain 16 107 0.5× 129 1.0× 51 0.6× 20 0.2× 34 0.4× 43 740
Richard J. Ptachcinski United States 17 171 0.7× 169 1.3× 227 2.7× 83 1.0× 79 0.9× 29 1.2k
John R. Petersen United States 20 175 0.8× 278 2.2× 26 0.3× 83 1.0× 44 0.5× 64 1.1k
Bryan L. Love United States 15 142 0.6× 163 1.3× 35 0.4× 109 1.3× 53 0.6× 52 894
Brendan Crotty Australia 18 310 1.3× 167 1.3× 24 0.3× 92 1.1× 127 1.5× 38 1.3k
Arianna Pani Italy 19 290 1.3× 176 1.4× 62 0.7× 72 0.8× 193 2.3× 61 1.2k
Kirandeep Kaur India 15 209 0.9× 149 1.2× 14 0.2× 66 0.8× 124 1.5× 66 637

Countries citing papers authored by S. James Matthews

Since Specialization
Citations

This map shows the geographic impact of S. James Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. James Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. James Matthews more than expected).

Fields of papers citing papers by S. James Matthews

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. James Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. James Matthews. The network helps show where S. James Matthews may publish in the future.

Co-authorship network of co-authors of S. James Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of S. James Matthews. A scholar is included among the top collaborators of S. James Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. James Matthews. S. James Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edwards, Roger, Jennifer L. Kirwin, Michael J. Gonyeau, et al.. (2014). A Reflective Teaching Challenge to Motivate Educational Innovation. American Journal of Pharmaceutical Education. 78(5). 103–103. 11 indexed citations
2.
Jaquiery, Anne L., et al.. (2013). Unpredictable Feeding Impairs Glucose Tolerance in Growing Lambs. PLoS ONE. 8(4). e61040–e61040. 4 indexed citations
3.
Matthews, S. James & Jason W. Lancaster. (2012). Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor. Clinical Therapeutics. 34(9). 1857–1882. 28 indexed citations
4.
Lancaster, Jason W. & S. James Matthews. (2012). Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections. Clinical Therapeutics. 34(1). 1–13. 37 indexed citations
5.
DiVall, Margarita V., Judith T. Barr, Michael J. Gonyeau, et al.. (2012). Follow-up Assessment of a Faculty Peer Observation and Evaluation Program. American Journal of Pharmaceutical Education. 76(4). 61–61. 33 indexed citations
6.
Matthews, S. James & Jason W. Lancaster. (2011). Urinary Tract Infections in the Elderly Population. ˜The œAmerican journal of geriatric pharmacotherapy. 9(5). 286–309. 104 indexed citations
7.
Matthews, S. James & Jason W. Lancaster. (2009). Doripenem monohydrate, a broad-spectrum carbapenem antibiotic. Clinical Therapeutics. 31(1). 42–63. 41 indexed citations
8.
Trujillo, Jennifer, Margarita V. DiVall, Judith T. Barr, et al.. (2008). Development of a Peer Teaching-Assessment Program and a Peer Observation and Evaluation Tool. American Journal of Pharmaceutical Education. 72(6). 147–147. 29 indexed citations
9.
Matthews, S. James. (2006). Entecavir for the treatment of chronic hepatitis B virus infection. Clinical Therapeutics. 28(2). 184–203. 53 indexed citations
10.
Matthews, S. James & Christopher McCoy. (2004). Peginterferon alfa-2a: A review of approved and investigational uses. Clinical Therapeutics. 26(7). 991–1025. 51 indexed citations
11.
Matthews, S. James & Christopher McCoy. (2003). Thalidomide: A review of approved and investigational uses. Clinical Therapeutics. 25(2). 342–395. 139 indexed citations
12.
McCoy, Christopher & S. James Matthews. (2003). Drotrecogin alfa (recombinant human activated protein C) for the treatment of severe sepsis. Clinical Therapeutics. 25(2). 396–421. 14 indexed citations
13.
Cersosimo, Robert J. & S. James Matthews. (1987). Hepatotoxicity Associated with Choline Magnesium Trisalicylate: Case Report and Review of Salicylate-Induced Hepatotoxicity. Drug Intelligence & Clinical Pharmacy. 21(7-8). 621–625.
14.
Matthews, S. James & Robert J. Cersosimo. (1986). Haloperidol Induced Neuroleptic Malignant Syndrome. 4(1). 33–41. 1 indexed citations
15.
Matthews, S. James, et al.. (1986). A Clinical manual of adverse drug reactions. Medical Entomology and Zoology. 2 indexed citations
16.
Cersosimo, Robert J., et al.. (1985). Bleomycin Pneumonitis Potentiated by Oxygen Administration. Drug Intelligence & Clinical Pharmacy. 19(12). 921–923. 11 indexed citations
17.
Matthews, S. James, et al.. (1981). Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis. Clinical Pharmacology & Therapeutics. 29(3). 322–326. 12 indexed citations
18.
Gleckman, Richard A., et al.. (1979). Drug therapy reviews: Oxolinic acid. American Journal of Health-System Pharmacy. 36(8). 1077–1079. 17 indexed citations
19.
Gleckman, Richard A., et al.. (1979). Drug therapy reviews: Methenamine mandelate and methenamine hippurate. American Journal of Health-System Pharmacy. 36(11). 1509–1512. 13 indexed citations
20.
Gleckman, Richard A., et al.. (1979). Drug therapy reviews: Nalidixic acid. American Journal of Health-System Pharmacy. 36(8). 1071–1076. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026